3D Printed Plastics Could Replace Metallic Collimators
|
By MedImaging International staff writers Posted on 18 Nov 2019 |

Image: Plastic collimator samples made using 3D printing (Photo courtesy of TPU)
3D printing of plastic collimators for external beam radiation therapy (EBRT) could improve accuracy and reduce dose delivery and collimator manufacturing time, claims a new study.
In order to develop the plastic collimators, researchers at Tomsk Polytechnic University (TPU; Russia), Moscow City Oncology Hospital No. 62 (Russia), and University Hospital Hamburg-Eppendorf (UKE; Germany) first used a numerical model to study the capability of high impact polystyrene (HIS) and acrylonitrile butadiene styrene (ABS) plastics to absorb an electron beam, and the required thickness and manufacturing method needed for the printed collimator to completely absorb the EBRT dose.
They then used the plastics to manufacture the first products through the method of layer-by-layer fused deposition modeling, using rapid prototyping. As the manufacturing process can affect crucial properties, such as material homogeneity (due to the presence of residual air-filled cavities), Monte Carlo simulations were used to determine electron depth dose distribution. The appropriate thickness for total absorption of 6 MeV electron beams was found tobe at least 4 cm, at least 8 cm for 12 MeV, and 11 cm for 20 MeV. The study was published in the August 2019 issue of Physica Medica.
“Metal collimators should be 1.6 cm thick to absorb the beam but, unlike metal, plastic does not have the same density and a number of other characteristics. We conducted a number of calculations and experiments to determine the thickness of a plastic product,” said senior author Sergei Stuchebrov, PhD, of the TPU Research School of High-Energy Physics. “For instance, we used special dosimeters, placed inside the plastic, to measure the depth distribution of the electron beam. The results can be used to further develop 3D printing procedures for medical electron beam profile formation.”
Collimators allow radiotherapy treatment (RT) flexibility in shielding organs-at-risk (OAR), while ensuring that the prescribed dose is delivered to the target. While in linear RT, a multi-leaf collimator (MLC) can be used to align the treatment field parallel to the radiation field and to the shape of the tumor, EBRT works from multiple directions, requiring fabrication of a patient-specific collimator using hand-crafted blocks.
Related Links:
Tomsk Polytechnic University
Moscow City Oncology Hospital No. 62
University Hospital Hamburg-Eppendorf
In order to develop the plastic collimators, researchers at Tomsk Polytechnic University (TPU; Russia), Moscow City Oncology Hospital No. 62 (Russia), and University Hospital Hamburg-Eppendorf (UKE; Germany) first used a numerical model to study the capability of high impact polystyrene (HIS) and acrylonitrile butadiene styrene (ABS) plastics to absorb an electron beam, and the required thickness and manufacturing method needed for the printed collimator to completely absorb the EBRT dose.
They then used the plastics to manufacture the first products through the method of layer-by-layer fused deposition modeling, using rapid prototyping. As the manufacturing process can affect crucial properties, such as material homogeneity (due to the presence of residual air-filled cavities), Monte Carlo simulations were used to determine electron depth dose distribution. The appropriate thickness for total absorption of 6 MeV electron beams was found tobe at least 4 cm, at least 8 cm for 12 MeV, and 11 cm for 20 MeV. The study was published in the August 2019 issue of Physica Medica.
“Metal collimators should be 1.6 cm thick to absorb the beam but, unlike metal, plastic does not have the same density and a number of other characteristics. We conducted a number of calculations and experiments to determine the thickness of a plastic product,” said senior author Sergei Stuchebrov, PhD, of the TPU Research School of High-Energy Physics. “For instance, we used special dosimeters, placed inside the plastic, to measure the depth distribution of the electron beam. The results can be used to further develop 3D printing procedures for medical electron beam profile formation.”
Collimators allow radiotherapy treatment (RT) flexibility in shielding organs-at-risk (OAR), while ensuring that the prescribed dose is delivered to the target. While in linear RT, a multi-leaf collimator (MLC) can be used to align the treatment field parallel to the radiation field and to the shape of the tumor, EBRT works from multiple directions, requiring fabrication of a patient-specific collimator using hand-crafted blocks.
Related Links:
Tomsk Polytechnic University
Moscow City Oncology Hospital No. 62
University Hospital Hamburg-Eppendorf
Latest Nuclear Medicine News
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
Channels
Radiography
view channel
AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
Osteoarthritis, a degenerative joint disease affecting over 500 million people worldwide, is the leading cause of disability among older adults. Current diagnostic tools allow doctors to assess damage... Read more
AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
Cardiovascular disease remains the leading cause of death in women worldwide, responsible for about nine million deaths annually. Despite this burden, symptoms and risk factors are often under-recognized... Read moreMRI
view channel
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read moreUltrasound
view channel
Ultrasound Probe Images Entire Organ in 4D
Disorders of blood microcirculation can have devastating effects, contributing to heart failure, kidney failure, and chronic diseases. However, existing imaging technologies cannot visualize the full network... Read more
Disposable Ultrasound Patch Performs Better Than Existing Devices
Wearable ultrasound devices are widely used in diagnostics, rehabilitation monitoring, and telemedicine, yet most existing models rely on lead-based piezoelectric ceramics that pose health and environmental risks.... Read moreGeneral/Advanced Imaging
view channel
New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more
AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
In pancreatic cancer, detecting whether the disease has spread to other organs is critical for determining whether surgery is appropriate. If metastasis is present, surgery is not recommended, yet current... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read morePatient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more







